
EUMCA News
You can contact our Communications Director at Penny.Lukats@eumca.org or +44 7775 992 350
EUMCA & Clever Leaves policy paper explains why CBD is not a narcotic
Professor Trevor Jones CBE FMedSci, says: “CBD is NOT a narcotic. The uncertainty about the legal status CBD, especially of plant-derived CBD, is a barrier to its medical use.” Professor Trevor Jones, Chair of the EUMCA urges the Commission to agree to the WHO...
Tilray Medical Cannabis Product Shows Promise Reducing Nausea and Vomiting Caused by Chemotherapy in World First Clinical Trial
Founding member of the EUMCA Tilray has reported that a clinical trial on its GMP medicinal cannabis product shows promise of reducing nausea and vomiting caused by chemotherapy. The results, published in the Annals of Oncology, found a significant improvement in the...
Clever Leaves’ Portugal Operation Granted License to Cultivate, Sell, and Export Medical Cannabis
License marks commencement of European cultivation activities and establishes Portugal as Clever Leaves’ European medical cannabis production hub New York, Lisbon, August 25, 2020 – Clever Leaves (the “Company”), a leading multi-national operator and licensed producer...
EU market for medical cannabis still far from full bloom – Professor Trevor Jones CBE comments
Professor Trevor Jones CBE FMedSci, chair of the EUMCA, says “As a result, quality standards may vary in each country in the absence of an overarching benchmark for quality at EU level. Building a homogeneous set of quality standards for medical cannabis is crucial...
The EUMCA: Pioneering access to medicinal cannabis – via Open Access Government
“Patients should have the right to know what they are buying or being prescribed is of proper quality. Currently, there is no real agreement on what analytical methodology should be used to check the quality nor what standards we should set, for instance, for CBD. My...
EUMCA calls for policymakers to reduce the lower THC limit in the German Monograph
Sita Schubert, Secretary General of the European Medicinal Cannabis Association, says: “Reducing the lower THC limit is imperative, and failure to make this amendment will deny patients, particularly younger patients, access to treatment.”EUMCA calls for policymakers...
Get in touch
Please submit your membership enquiry and our team will be in touch to discuss
Or call +32 233 90 281

Dive straight into the feedback!Login below and you can start commenting using your own user instantly